Halozyme Therapeutics reported $1.5B in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 38.94B 241M
Aptinyx Inc APTX:US USD 24.71M 211K
Baxter International BAX:US USD 16.43B 254M
Cytokinetics CYTK:US USD 610.73M 411.31M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Intrexon XON:US USD 82.07M 116.6M
IONIS PHARMACEUT IONS:US USD 1.25B 1.34M
JAZZ PHA JAZZ:US USD 5.73B 294.18M
Mannkind MNKD:US USD 377.03M 564K
Peregrine Pharmaceuticals PPHM:US USD 142.44M 134K
Rigel Pharmaceuticals RIGL:US USD 39.47M 9.63M
United Therapeutics UTHR:US USD 800M 0